C122H118Cl8N32O11 — CID 160838903
3-[(2S)-2-[5-chloro-4-(4-methylphenyl)-1H-imidazol-2-yl]-2-[[5-chloro-2-(tetrazol-1-yl)phenyl]methylcarbamoylamino]ethyl]benzoic acid;3-[(2S)-2-[5-chloro-4-(4-methylphenyl)-1H-imidazol-2-yl]-2-[[5-chloro-2-(tetrazol-1-yl)phenyl]methylcarbamoylamino]ethyl]-N-methylbenzamide;1-[(1S)-1-[5-chloro-4-(4-methylphenyl)-1H-imidazol-2-yl]-2-phenylethyl]-3-[(5-chloro-2-pyrrolidin-1-ylphenyl)methyl]urea;propyl N-[4-[5-chloro-2-[(1S)-1-[[5-chloro-2-(tetrazol-1-yl)phenyl]methylcarbamoylamino]-2-[3-(morpholine-4-carbonyl)phenyl]ethyl]-1H-imidazol-4-yl]phenyl]carbamate (PubChem CID 160838903) has the molecular formula C122H118Cl8N32O11 and a molecular weight of 2492.12 g/mol. Its IUPAC name is 3-[(2S)-2-[5-chloro-4-(4-methylphenyl)-1H-imidazol-2-yl]-2-[[5-chloro-2-(tetrazol-1-yl)phenyl]methylcarbamoylamino]ethyl]benzoic acid;3-[(2S)-2-[5-chloro-4-(4-methylphenyl)-1H-imidazol-2-yl]-2-[[5-chloro-2-(tetrazol-1-yl)phenyl]methylcarbamoylamino]ethyl]-N-methylbenzamide;1-[(1S)-1-[5-chloro-4-(4-methylphenyl)-1H-imidazol-2-yl]-2-phenylethyl]-3-[(5-chloro-2-pyrrolidin-1-ylphenyl)methyl]urea;propyl N-[4-[5-chloro-2-[(1S)-1-[[5-chloro-2-(tetrazol-1-yl)phenyl]methylcarbamoylamino]-2-[3-(morpholine-4-carbonyl)phenyl]ethyl]-1H-imidazol-4-yl]phenyl]carbamate.
| Compound Name | 3-[(2S)-2-[5-chloro-4-(4-methylphenyl)-1H-imidazol-2-yl]-2-[[5-chloro-2-(tetrazol-1-yl)phenyl]methylcarbamoylamino]ethyl]benzoic acid;3-[(2S)-2-[5-chloro-4-(4-methylphenyl)-1H-imidazol-2-yl]-2-[[5-chloro-2-(tetrazol-1-yl)phenyl]methylcarbamoylamino]ethyl]-N-methylbenzamide;1-[(1S)-1-[5-chloro-4-(4-methylphenyl)-1H-imidazol-2-yl]-2-phenylethyl]-3-[(5-chloro-2-pyrrolidin-1-ylphenyl)methyl]urea;propyl N-[4-[5-chloro-2-[(1S)-1-[[5-chloro-2-(tetrazol-1-yl)phenyl]methylcarbamoylamino]-2-[3-(morpholine-4-carbonyl)phenyl]ethyl]-1H-imidazol-4-yl]phenyl]carbamate |
|---|---|
| PubChem CID | 160838903 |
| Molecular Formula | C122H118Cl8N32O11 |
| Molecular Weight | 2492.12 g/mol |
| Exact Mass | 2486.72 |
| IUPAC Name | 3-[(2S)-2-[5-chloro-4-(4-methylphenyl)-1H-imidazol-2-yl]-2-[[5-chloro-2-(tetrazol-1-yl)phenyl]methylcarbamoylamino]ethyl]benzoic acid;3-[(2S)-2-[5-chloro-4-(4-methylphenyl)-1H-imidazol-2-yl]-2-[[5-chloro-2-(tetrazol-1-yl)phenyl]methylcarbamoylamino]ethyl]-N-methylbenzamide;1-[(1S)-1-[5-chloro-4-(4-methylphenyl)-1H-imidazol-2-yl]-2-phenylethyl]-3-[(5-chloro-2-pyrrolidin-1-ylphenyl)methyl]urea;propyl N-[4-[5-chloro-2-[(1S)-1-[[5-chloro-2-(tetrazol-1-yl)phenyl]methylcarbamoylamino]-2-[3-(morpholine-4-carbonyl)phenyl]ethyl]-1H-imidazol-4-yl]phenyl]carbamate |
| SMILES | CCCOC(=O)Nc1ccc(-c2nc([C@H](Cc3cccc(C(=O)N4CCOCC4)c3)NC(=O)NCc3cc(Cl)ccc3-n3cnnn3)[nH]c2Cl)cc1.CNC(=O)c1cccc(C[C@H](NC(=O)NCc2cc(Cl)ccc2-n2cnnn2)c2nc(-c3ccc(C)cc3)c(Cl)[nH]2)c1.Cc1ccc(-c2nc([C@H](Cc3cccc(C(=O)O)c3)NC(=O)NCc3cc(Cl)ccc3-n3cnnn3)[nH]c2Cl)cc1.Cc1ccc(-c2nc([C@H](Cc3ccccc3)NC(=O)NCc3cc(Cl)ccc3N3CCCC3)[nH]c2Cl)cc1 |
| InChI | InChI=1S/C35H36Cl2N10O5.C30H31Cl2N5O.C29H27Cl2N9O2.C28H24Cl2N8O3/c1-2-14-52-35(50)40-27-9-6-23(7-10-27)30-31(37)43-32(42-30)28(18-22-4-3-5-24(17-22)33(48)46-12-15-51-16-13-46)41-34(49)38-20-25-19-26(36)8-11-29(25)47-21-39-44-45-47;1-20-9-11-22(12-10-20)27-28(32)36-29(35-27)25(17-21-7-3-2-4-8-21)34-30(38)33-19-23-18-24(31)13-14-26(23)37-15-5-6-16-37;1-17-6-8-19(9-7-17)25-26(31)37-27(36-25)23(13-18-4-3-5-20(12-18)28(41)32-2)35-29(42)33-15-21-14-22(30)10-11-24(21)40-16-34-38-39-40;1-16-5-7-18(8-6-16)24-25(30)35-26(34-24)22(12-17-3-2-4-19(11-17)27(39)40)33-28(41)31-14-20-13-21(29)9-10-23(20)38-15-32-36-37-38/h3-11,17,19,21,28H,2,12-16,18,20H2,1H3,(H,40,50)(H,42,43)(H2,38,41,49);2-4,7-14,18,25H,5-6,15-17,19H2,1H3,(H,35,36)(H2,33,34,38);3-12,14,16,23H,13,15H2,1-2H3,(H,32,41)(H,36,37)(H2,33,35,42);2-11,13,15,22H,12,14H2,1H3,(H,34,35)(H,39,40)(H2,31,33,41)/t28-;25-;23-;22-/m0000/s1 |
| InChIKey | SHTORNFHGVHFMU-CCEVJIOXSA-N |
| XLogP | 22.61 |
| TPSA | 547.55 Ų |
| H-Bond Donors | 15 |
| H-Bond Acceptors | 27 |
| Rotatable Bonds | 38 |
| Heavy Atoms | 173 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2492.12 |
| LogP ≤ 5 | 22.61 |
| H-Bond Donors ≤ 5 | 15 |
| H-Bond Acceptors ≤ 10 | 27 |